---
document_datetime: 2023-09-21 18:58:04
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/juluca-epar-all-authorised-presentations_en.pdf
document_name: juluca-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7375632
conversion_datetime: 2025-12-22 00:14:22.362837
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength      | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size                       |
|------------------|-------------------|---------------|-----------------------|---------------------------|-----------------------|---------------------------------|
| EU/1/18/1282/001 | Juluca            | 50 mg / 25 mg | Film-coated tablet    | Oral use Oral             | bottle (HDPE)         | 30 tablets                      |
| EU/1/18/1282/002 | Juluca            | 50 mg / 25 mg | Film-coated tablet    | use                       | bottle (HDPE)         | 90 (3 x 30) tablets (multipack) |